EP Patent

EP1051490A2 — Modulation of cell proliferation, methods and reagents

Assigned to Cold Spring Harbor Laboratory · Expires 2000-11-15 · 26y expired

What this patent protects

The present invention relates to polypeptides capable of bypassing a cell cycle checkpoint. Specific applications for inducing cell growth using such polypeptides (e.g., a macrophage migration inhibitory factor) are described.

USPTO Abstract

The present invention relates to polypeptides capable of bypassing a cell cycle checkpoint. Specific applications for inducing cell growth using such polypeptides (e.g., a macrophage migration inhibitory factor) are described.

Drugs covered by this patent

mechlorethamine-hydrochloride (MECHLORETHAMINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP1051490A2
Jurisdiction: EP
Classification: —
Expires: 2000-11-15
Drug substance claim: No
Drug product claim: No
Assignee: Cold Spring Harbor Laboratory
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.